发明名称 Inhibitors of poly(ADP-ribose)polymerase
摘要 Inhibitors of poly(ADP-ribose)polymerase, ways to make them and methods of treating patients using them are disclosed.
申请公布号 US9283222(B2) 申请公布日期 2016.03.15
申请号 US201313902055 申请日期 2013.05.24
申请人 AbbVie Inc. 发明人 Gandhi Virajkumar B.;Giranda Vincent L.;Gong Jianchun;Penning Thomas D.;Zhu Gui-Dong
分类号 A61K31/502;C07D237/32;C07D401/12;C07D401/14;C07D403/10;C07D403/12;C07D403/14;A61K31/551;A61K45/06;A61N5/10 主分类号 A61K31/502
代理机构 代理人 Gesicki Glen J.
主权项 1. A method of treating leukemia, colon cancer, carcinomas of the breast, or cervical carcinomas in a mammal comprising administering thereto a therapeutically acceptable amount of a compound of selected from the group consisting of 4-(3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl)-5,6,7,8-tetrahydrophthalazin-1(2h)-one; 4-((2-fluoro-5-((4-oxo-3,4,5,6,7,8-hexahydrophthalazin-1-yl)methyl)phenyl)amino)-4-oxobutanoic acid; and 1-(2-fluoro-5-((4-oxo-3,4,5,6,7,8-hexahydrophthalazin-1-yl)methyl)phenyl)pyrrolidine-2,5-dione; or a pharmaceutically acceptable salt thereof.
地址 North Chicago IL US